Adaptive Biotechnologies CorporationADPTNASDAQ
Loading
Operating Expenses Over TimeStable
Percentile Rank50
3Y CAGR-7.1%
5Y CAGR+2.8%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-7.1%/yr
vs +39.8%/yr prior
5Y CAGR
+2.8%/yr
Recent deceleration
Acceleration
-46.9pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
3 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $262.74M | -2.5% |
| 2024 | $269.43M | -16.3% |
| 2023 | $321.76M | -1.8% |
| 2022 | $327.58M | +4.3% |
| 2021 | $314.01M | +37.3% |
| 2020 | $228.67M | +62.0% |
| 2019 | $141.19M | +64.6% |
| 2018 | $85.75M | +29.1% |
| 2017 | $66.40M | - |